The platform will be applied across Axxam’s integrated discovery services, in fields such as pharmaceuticals, crop protection, animal health, and food and beverages
Using a substrain of E. coli MG 1655 and nanoscale red blood cell membranes, researchers created tiny biohybrid swimmers that could personalize drug delivery to treat tumors